TokenPost·

Bausch + Lomb's BL1332 Misses Primary Goal in Phase 2 Eye Pain Trial

Your call?

At 24 hours, the topical drug for pain after eye surgery showed no statistically significant improvement over vehicle, an inactive comparison formulation.

Share

More news